Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

151.82 +4.36 (+2.96%)
Streaming Delayed Price Updated: 10:48 AM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
From Insulet Corporation
Via Business Wire
News headline image
2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Topics Artificial Intelligence
News headline image
Insulet Corp (NASDAQ:PODD) Presents a Classic Growth at a Reasonable Price (GARP) Case ↗
Insulet Corp (PODD) exemplifies Growth at a Reasonable Price (GARP) with strong earnings growth, solid financials, and a valuation justified by its sector and future potential. 
Via Chartmill
News headline image
Insulet Corp (NASDAQ:PODD) Passes Key Growth Stock Screen from "The Little Book That Makes You Rich" ↗
Insulet Corp (PODD) exemplifies a high-growth stock, meeting key criteria for accelerating earnings, sales, and cash flow with strong profitability. 
Via Chartmill
News headline image
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
From Insulet Corporation
Via Business Wire
News headline image
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
From Insulet Corporation
Via Business Wire
News headline image
Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Friday's session: top gainers and losers in the S&P500 index ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's session ↗
Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
2 High-Flying Stocks with Impressive Fundamentals and 1 We Turn Down
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
Topics Energy
News headline image
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
From Insulet Corporation
Via Business Wire
News headline image
Insulet Corp. (NASDAQ:PODD) Embodies a Proven Growth Investing Strategy ↗
Insulet Corp. exemplifies a disciplined growth investing strategy, showcasing accelerating revenue, earnings, and cash flow that meet strict financial filters for stock selection. 
Via Chartmill
News headline image
2 Growth Stocks with Explosive Upside and 1 We Find Risky
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Monday. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
3 Quality Compounders to Keep an Eye On
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more profits. Rinse and repeat. 
Via StockStory
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
News headline image
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
From Insulet Corporation
Via Business Wire
News headline image
Peering Into Insulet Corp's Recent Short Interest ↗
 
Via Benzinga
News headline image
Insulet Corp (NASDAQ:PODD) Presents a Compelling Affordable Growth Opportunity ↗
Insulet Corp (PODD) offers strong growth and profitability at a reasonable valuation. Its solid financial health makes it a top affordable growth stock. 
Via Chartmill
News headline image
$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
3 Reasons We Love Insulet (PODD)
Since May 2025, Insulet has been in a holding pattern, posting a small return of 3% while floating around $335.74. The stock also fell short of the S&P 500’s 11.9% gain during that period. 
Via StockStory
Topics Stocks
News headline image
Insulet Corp (PODD) Shows Strong Technical and Fundamental Momentum ↗
Discover how Insulet Corp (PODD) combines strong technical uptrends with high-growth fundamentals, presenting a potential market leader for growth investors. 
Via Chartmill
News headline image
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Insulet Corp (NASDAQ:PODD) Passes Stringent Growth Screen ↗
Discover how Insulet Corp exemplifies a powerful growth investing system, showcasing strong earnings, soaring sales, and impressive cash flow. 
Via Chartmill
News headline image
Gapping S&P500 stocks in Thursday's session ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter ↗
Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.